News & Updates
Filter by Specialty:
Antirheumatic drugs confer cardioprotection, too
Treatments used in rheumatoid arthritis, called disease-modifying antirheumatic drugs, can also lower the risk of heart disease among patients, as shown in a recent study.
Antirheumatic drugs confer cardioprotection, too
14 Dec 2022
Total ankle replacement vs arthrodesis: Which is better for ankle osteoarthritis?
Total ankle replacement (TAR) and ankle fusion (AF) or arthrodesis both improve the Manchester–Oxford Foot Questionnaire walking/standing (MOXFQ-W/S) domain scores in patients with end-stage ankle osteoarthritis at 52 weeks after surgery, reports a study. The two surgical treatments also show similar clinical scores and number of harms.
Total ankle replacement vs arthrodesis: Which is better for ankle osteoarthritis?
01 Dec 2022
Fatigue worsens quality of life, productivity in patients with psoriatic arthritis
Patients with psoriatic arthritis (PsA) usually complain of fatigue, which is less frequently diagnosed by many physicians, reports a study. Severe fatigue may lead to poorer physical functioning, work productivity, and health-related quality of life (HRQOL).
Fatigue worsens quality of life, productivity in patients with psoriatic arthritis
25 Nov 2022
Immunosuppressant exposure tied to guideline-congruent cervical cancer screening
Guideline-congruent screening for cervical cancer remains poor in women with systemic lupus erythematosus (SLE), according to a study.
Immunosuppressant exposure tied to guideline-congruent cervical cancer screening
24 Nov 2022
Anifrolumab for SLE shows favourable benefit–risk profile in extension study
Patients with moderate-to-severe systemic lupus erythematosus (SLE) appear to fare well with anifrolumab, with a recent study showing that the drug has an acceptable long-term safety profile and helps maintain reductions in disease activity and glucocorticoid usage.